Attorney General Pam Bondi News Release

November 15, 2012
Contact: Whitney Ray
Phone: (850) 245-0150

Attorney General Pam Bondi and 37 Other Attorneys General Reach a $90 Million Settlement with GlaxoSmithKline Concerning the Diabetes Drug Avandia

TALLAHASSEE, Fla. –Attorney General Pam Bondi announced that she and 37 other attorneys general have reached a $90 million settlement with GlaxoSmithKline, LLC (GSK) to resolve allegations that GSK unlawfully promoted the diabetes drug Avandia. In a complaint filed today, Attorney General Pam Bondi alleges that GSK engaged in unfair and deceptive practices by misrepresenting Avandia’s cardiovascular risks and safety profile. As part of the settlement, GSK agreed to reform how it markets and promotes diabetes drugs.

“Misleading patients about a medication's safety profile and cardiovascular risks is dangerous,” stated Attorney General Pam Bondi. “GlaxoSmithKline is now required to safely and properly promote its diabetes drug, Avandia.”

Under the consent judgment, GSK may not:
The judgment also has the following terms that are effective for at least eight years:
The investigation’s executive committee consisted of the Attorneys General from Florida, Arizona, Illinois, Maryland, Oregon, Pennsylvania, Tennessee, and Texas. Also participating in the settlement are: Alabama, Alaska, Arkansas, California, Colorado, Connecticut, Delaware, the District of Columbia, Hawaii, Idaho, Iowa, Kansas, Maine, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nebraska, Nevada, New Jersey, North Carolina, North Dakota, Ohio, Oklahoma, Rhode Island, South Dakota, Vermont, Washington, and Wisconsin.

A copy of the consent judgment is available here:$file/ConsentSignedbyJudgeTuter.pdf

A copy of the complaint is available here:$file/ComplaintsignedbyJudgeTuter.pdf